121 related articles for article (PubMed ID: 38599833)
1. Prognostic Implications of N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Non-ST-Elevation Myocardial Infarction.
Kim CH; Lee SH; Kim HK; Kim MC; Kim JH; Hong YJ; Ahn YK; Jeong MH; Hur SH; Kim DI; Chang K; Park HS; Bae JW; Jeong JO; Park YH; Yun KH; Yoon CH; Kim Y; Hwang JY; Kim HS; Choi KH; Park TK; Yang JH; Song YB; Hahn JY; Choi SH; Gwon HC; Lee JM;
Circ J; 2024 Apr; ():. PubMed ID: 38599833
[TBL] [Abstract][Full Text] [Related]
2. Association between N-terminal pro-BNP and 12 months major adverse cardiac events among patients admitted with NSTEMI.
Gong X; Zhang T; Feng S; Song D; Chen Y; Yao T; Han P; Liu Y; Li C; Song Z; Gao J; Cui Z; Ma J; Liu Y
Ann Palliat Med; 2021 May; 10(5):5231-5243. PubMed ID: 34044561
[TBL] [Abstract][Full Text] [Related]
3. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.
Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A
Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480
[TBL] [Abstract][Full Text] [Related]
4. Improved heart function and cardiac remodelling following sacubitril/valsartan in acute coronary syndrome with HF.
Liu H; Su Y; Shen J; Jiao Y; Li Y; Liu B; Hou X; Jin Q; Chen Y; Sun Z; Xi Q; Feng B; Fu Z
ESC Heart Fail; 2024 Apr; 11(2):937-949. PubMed ID: 38224955
[TBL] [Abstract][Full Text] [Related]
5. Biomarker for the Prediction of Major Adverse Cardiac Events in Patients with Non-ST-Segment Elevation Myocardial Infarction.
Shon HS; Bae JW; Kim KO; Cha EJ; Kim KA
Osong Public Health Res Perspect; 2017 Aug; 8(4):237-246. PubMed ID: 28904845
[TBL] [Abstract][Full Text] [Related]
6. The association of baseline N-terminal pro-B-type natriuretic peptide with short and long-term prognosis following percutaneous coronary intervention in non-ST segment elevation acute coronary syndrome with multivessel coronary artery disease: a retrospective cohort study.
He WF; Jiang L; Chen YY; Liu YH; Chen PY; Duan CY; Zeng LH; Fan HL; Wei XB; Guo W; Chen W; Li J; Li WS; Guo ZQ; Liu ZK; Tan N; Chen JY; He PC
BMC Cardiovasc Disord; 2021 Apr; 21(1):202. PubMed ID: 33882836
[TBL] [Abstract][Full Text] [Related]
7. [Safety and efficacy of the early administration of levosimendan in patients with acute non-ST-segment elevation myocardial infarction and elevated NT-proBNP levels: An Early Management Strategy of Acute Heart Failure (EMS-AHF)].
Xu F; Bian Y; Zhang GQ; Gao LY; Liu YF; Liu TX; Li G; Song RX; Su LJ; Zhou YJ; Cui JY; Yan XL; Guo FM; Zhang HY; Li QH; Zhao M; Ma LK; You BA; Wang G; Kong L; Ma JL; Zhou XF; Chang ZL; Tang ZY; Yu DY; Cheng K; Xue L; Li X; Pang JJ; Wang JL; Zhang HT; Yu XZ; Chen YG
Zhonghua Nei Ke Za Zhi; 2023 Apr; 62(4):374-383. PubMed ID: 37032132
[No Abstract] [Full Text] [Related]
8. [Relationship between plasma N-terminal pro-brain natriuretic peptide and GRACE risk stratification in non-ST-segment elevation acute coronary syndrome].
Liu WX; Zhao H
Zhonghua Xin Xue Guan Bing Za Zhi; 2012 May; 40(5):373-7. PubMed ID: 22883085
[TBL] [Abstract][Full Text] [Related]
9. NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation.
Niccoli G; Conte M; Marchitti S; Montone RA; Fracassi F; Grippo R; Roberto M; Burzotta F; Trani C; Leone AM; Bianchi F; Di Castro S; Volpe M; Crea F; Rubattu S
Cardiovasc Revasc Med; 2016; 17(3):162-8. PubMed ID: 26987266
[TBL] [Abstract][Full Text] [Related]
10. Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial.
Jarai R; Huber K; Bogaerts K; Droogne W; Ezekowitz J; Granger CB; Sinnaeve PR; Ross AM; Zeymer U; Armstrong PW; Van de Werf FJ;
Am Heart J; 2010 Jan; 159(1):131-40. PubMed ID: 20102879
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of N-terminal-pro-brain natriuretic peptide measurements in patients with acute coronary syndromes.
Ranjith N; Pegoraro RJ; Naidoo DP; Esterhuizen TM
Cardiovasc J S Afr; 2006; 17(2):60-6. PubMed ID: 16733598
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of serial N-terminal pro-B-type natriuretic peptide levels in patients with acute myocardial infarction: A prospective study.
Li N; Chen R; Li J; Zhao X; Wang Y; Zhou J; Zhou P; Liu C; Chen Y; Song L; Yan S; Zhao H; Yan H
Am Heart J; 2023 Aug; 262():90-99. PubMed ID: 37116605
[TBL] [Abstract][Full Text] [Related]
13. Optimization of GRACE Risk Stratification by N-Terminal Pro-B-type Natriuretic Peptide Combined With D-Dimer in Patients With Non-ST-Elevation Myocardial Infarction.
Lu PJ; Gong XW; Liu Y; Tian FS; Zhang WJ; Liu YW; Yao ZH; Wang JX; Han P; Yang YN; Cui Z; Gao J
Am J Cardiol; 2021 Feb; 140():13-19. PubMed ID: 33159905
[TBL] [Abstract][Full Text] [Related]
14. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention.
Kwon TG; Bae JH; Jeong MH; Kim YJ; Hur SH; Seong IW; Cho MC; Seung KB; Jang YS; Park SJ;
Int J Cardiol; 2009 Apr; 133(2):173-8. PubMed ID: 18281115
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 33 and ST2 in non-ST-elevation myocardial infarction: comparison with Global Registry of Acute Coronary Events Risk Scoring and NT-proBNP.
Dhillon OS; Narayan HK; Quinn PA; Squire IB; Davies JE; Ng LL
Am Heart J; 2011 Jun; 161(6):1163-70. PubMed ID: 21641364
[TBL] [Abstract][Full Text] [Related]
16. A combination of increased Rho kinase activity and N-terminal pro-B-type natriuretic peptide predicts worse cardiovascular outcome in patients with acute coronary syndrome.
Dong M; Liao JK; Yan B; Li R; Zhang M; Yu CM
Int J Cardiol; 2013 Sep; 167(6):2813-9. PubMed ID: 22921817
[TBL] [Abstract][Full Text] [Related]
17. Improved early risk stratification of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention using a combination of serum soluble ST2 and NT-proBNP.
Yu J; Oh PC; Kim M; Moon J; Park YM; Lee K; Suh SY; Han SH; Byun K; Ahn T; Kang WC
PLoS One; 2017; 12(8):e0182829. PubMed ID: 28796845
[TBL] [Abstract][Full Text] [Related]
18. NT-proBNP and Major Adverse Cardiovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Who Received Primary Percutaneous Coronary Intervention: A Prospective Cohort Study.
Qin Z; Du Y; Zhou Q; Lu X; Luo L; Zhang Z; Guo N; Ge L
Cardiol Res Pract; 2021; 2021():9943668. PubMed ID: 34765262
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of Preprocedural N-Terminal Pro-B-Type Natriuretic Peptide Assessment in Diabetic Patients With Multivessel Coronary Disease Undergoing Revascularization.
Wang L; Cong HL; Zhang JX; Hu YC; Li XM; Zhang YY; Wang L; Yang H; Ren LB; Qi W; Liu CW
Front Cardiovasc Med; 2021; 8():721260. PubMed ID: 34692781
[No Abstract] [Full Text] [Related]
20. Prognostic Value of NT-proBNP in Patients With Successful PCI for ACS and Normal Left Ventricular Ejection Fraction.
Wang JL; Guo CY; Li HW; Zhao XQ; Zhao SM
Am J Med Sci; 2022 Apr; 363(4):333-341. PubMed ID: 34986361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
